Literature DB >> 2023608

Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).

J L Walker1, M Ginalska-Malinowska, T E Romer, J B Pucilowska, L E Underwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2023608     DOI： 10.1056/NEJM199105233242107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Familial growth hormone insensitivity syndrome.

Authors:  A H Zargar; B A Laway; S R Masoodi; M Salahuddin; M A Siddiqui
Journal:  Indian J Pediatr       Date:  1995 Mar-Apr       Impact factor: 1.967

2.  Familial growth hormone insensitivity syndrome.

Authors:  A H Zargar; B A Laway; S R Masoodi; M Salahuddin; M A Siddiqui
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 3.  Insulin-like growth factor (IGF)-I gene deletion.

Authors:  Cecilia Camacho-Hübner; Katie A Woods; Adrian J L Clark; Martin O Savage
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 4.  Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

5.  Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis.

Authors:  C M Fernández-Rodriguez; I Prada; A Andrade; M Moreiras; R Guitián; R Aller; J L Lledó; G Cacho; J Quiroga; J Prieto
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

6.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

Authors:  K Sjögren; J L Liu; K Blad; S Skrtic; O Vidal; V Wallenius; D LeRoith; J Törnell; O G Isaksson; J O Jansson; C Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

7.  Effect of growth hormone on urine calcium and serum vitamin D metabolites in renal failure.

Authors:  C F Strife; G Hug
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

8.  The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.

Authors:  A J O'Sullivan; L J Crampton; J Freund; K K Ho
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Renal function in Laron syndrome patients treated by insulin-like growth factor-I.

Authors:  B Klinger; Z Laron
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

10.  Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.

Authors:  M A Hussain; O Schmitz; A Mengel; A Keller; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.